MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study

Figure 1

An influence of HPR on plasma concentration of MMP-2 (a), MMP-9 (b), and TIMP-4 (c). Mean ± SEM classification of HPR on the basis of LTA Amax > 20%. HPR-high on-aspirin treatment platelets reactivity; LTA: light transmittance aggregometry; MMP: matrix metalloproteinase; TIMP-4: tissue inhibitor of MMPs.

(a)

(b)

(c)